What is the primary purpose of this 8-K filing?

This Form 8-K filing primarily serves to report the certified voting results from CVS Health Corp.'s Annual Meeting of Shareholders held on May 9, 2007. These results were not announced at the meeting itself but were certified later.

Were all the directors elected by shareholders?

Yes, all nominated directors received a majority of the votes cast in favor of their election. However, C.A. Lance Piccolo and Roger L. Headrick received a significant number of votes against their election compared to other directors.

What was the outcome of the shareholder proposal regarding the separation of Chairman and CEO roles?

The shareholder proposal to separate the roles of Chairman and CEO received majority support from the votes cast. While this vote is non-binding, the company has stated that its Nominating and Corporate Governance Committee will carefully review the matter and consider an appropriate response.

What is the significance of the 'broker non-votes' noted in the report?

Broker non-votes occur when a broker holding shares in 'street name' for a customer does not receive voting instructions from the customer for a particular proposal. These non-votes do not count as 'votes cast' for or against a proposal, which can impact the outcome, especially for non-binding shareholder proposals.

CVS 8-K SEC Disclosure — May 16, 2007

Summary

This Form 8-K filed by CVS Health Corp. (then CVS Caremark Corporation) on May 16, 2007, provides the certified voting results from its Annual Meeting of Shareholders held on May 9, 2007. The report details the outcome of several proposals, including the election of directors, ratification of independent auditors, adoption of employee stock plans, and various shareholder proposals. A significant outcome was the shareholder vote in favor of separating the roles of Chairman and CEO, though this vote is non-binding, with the Nominating and Corporate Governance Committee committed to reviewing the matter. For investors, these results offer insights into shareholder sentiment regarding corporate governance and executive compensation. The strong majority support for most director nominations and the ratification of the independent auditor indicate general confidence in the board and financial oversight. However, the mixed results on shareholder proposals, particularly the non-binding approval for separating Chairman and CEO roles, suggest areas where the company may face ongoing shareholder engagement and potential future governance adjustments. The substantial number of broker non-votes on some proposals highlights the importance of proxy voting by beneficial owners.

Key Highlights

1Certified voting results from the May 9, 2007 Annual Meeting of Shareholders are officially reported.
2A quorum of 71.91% of total eligible votes was achieved.
3All incumbent directors nominated for election received majority support from votes cast, with the exception of C.A. Lance Piccolo and Roger L. Headrick who had a notable number of 'against' votes.
4KPMG LLP was ratified as the company's independent registered public accounting firm for the 2007 fiscal year with overwhelming support.
5Shareholders approved the adoption of the Company's 2007 Employee Stock Purchase Plan and the 2007 Incentive Plan.
6A non-binding shareholder proposal to separate the roles of Chairman and CEO received majority support (52.36% of votes cast), and the company's Nominating and Corporate Governance Committee will review this outcome.
7Several other shareholder proposals concerning CEO compensation, sustainability reporting, compensation consultants, and stock option grants did not receive majority support.

CVS HEALTH Corp 8-K Report, Corporate Update (May 16, 2007)

Summary

Key Highlights

Frequently Asked Questions